Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-13

Study Completion Date

2024-11-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an exploratory, non-interventional and translational clinical study. The aim of this study is to analyze blood and cerebrospinal fluid metabolomic profile in glioma patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CSF Proteomic Characterization of Glioblastomas

NCT06845020

Glioblastoma Glioblastoma WHO Grade IV Glioblastoma (GBM) +2 more

NOT_YET_RECRUITING

Natural History of Patients With Brain and Spinal Cord Tumors

NCT00009035

Astrocytoma Oligodendroglioma Glioblastoma +2 more

COMPLETED

Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma

NCT06885333

Glioma Glioma : Oligodendroglioma or Astrocytoma

COMPLETED

Immunophenotyping From Blood of Patients With Malignant Gliomas

NCT02022384

Anaplastic Astrocytoma Glioblastoma Multiforme

COMPLETED

Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers

NCT01638130

Brain Neoplasms, Primary Malignant

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The analysis of metabolic profile in the plasma and CSF could become the new less invasive approach in the establishing diagnosis as well as an important prognostic factor in patients with glioma. The researches will assess the blood and CSF metabolic profile in patients with different types of gliomas as well as in patient without ones. This can help to find new biomarkers for low- and high-grade gliomas correlating with patient outcomes.

Blood and CSF samples will be collected from patients with suspected newly diagnosed low-grade (I-II) or high-grade (III-IV) gliomas as well as from patients who have hospitalized for reconstructive surgery after craniofacial trauma. All samples will be collected before any surgical intervention and at various follow-up time points until progression or death. The results of the study are planned to be translated into the hospital setting as support to other diagnostics procedures and to the differential diagnosis between glioma grades.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glioma Glioblastoma Multiforme

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort 1 / High grade Glioma

Cohort 1:

1. Histologically confirmed high-grade glioma (grade III and grade IV (glioblastoma (GBM)))
2. Planned treatment (surgery followed by radiation therapy (RT) alone or Chemotherapy alone or a combination of RT/Chemotherapy)

Non- interventional

Intervention Type OTHER

Translational, observational study

Cohort 2 / Low grade Glioma

Cohort 2:

1. Histologically confirmed low-grade (grade I/II) glioma
2. Planned treatment either expectant monitoring or surgery followed by RT alone or Chemotherapy alone or a combination of RT/Chemotherapy

Non- interventional

Intervention Type OTHER

Translational, observational study

Cohort 3 / Conditionally healthy volunteers

Cohort 3:

1. No oncological disease was diagnosed
2. Planned treatment (reconstructive surgery after craniofacial trauma)

Non- interventional

Intervention Type OTHER

Translational, observational study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non- interventional

Translational, observational study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. All patients with suspected newly diagnosed glioma (grade I, II, III or glioblastoma) with planned surgical intervention (resection or biopsy).
2. Patient aged 18 years or older
3. Patients have to be able to give informed consent

Exclusion Criteria

1. Prior Radiotherapy to the central nervous system
2. Prior Chemotherapy within the last 5 years
3. Any prior central nervous system malignancy
4. Any surgery during last 6 month

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes